BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  American Diabetes Association Release: Lipid-Lowering Drugs Protect Against Peripheral Diabetic Neuropathy

  June 25, 2007

   · 

  6 min read
• Genetown

  HepaLife Technologies Inc.'s PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference

  June 25, 2007

   · 

  1 min read
• Drug Development

  Amylin Pharmaceuticals, Inc. Release: SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes

  June 25, 2007

   · 

  5 min read
• Business

  Experienced Biopharmaceutical Executive Steve Glover Joins Insmed Incorporated; Will Lead Development of Follow-on Biologics

  June 25, 2007

   · 

  1 min read
• Business

  TheraQuest Biosciences, LLC. Announces New Appointments to Its Scientific Advisory Board

  June 25, 2007

   · 

  2 min read
• Drug Development

  Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia(R) in Children Suffering From Vernal Keratoconjunctivitis

  June 25, 2007

   · 

  4 min read
• BioMidwest

  Orexigen Therapeutics, Inc. Reports Contrave(TM) Has Positive Effect on Visceral Fat and Insulin Resistance, Factors Believed to Contribute to the Risk of Heart Disease and Type II Diabetes

  June 25, 2007

   · 

  5 min read
• Pharm Country

  Memry Corporation Introduces New V2 Ultra Small Diameter Nitinol Tubing

  June 25, 2007

   · 

  3 min read
• Drug Development

  Molecular Insight Pharmaceuticals, Inc. Initiates First of Two Planned Pivotal Registration Trials for Zemiva(TM) in Detection of Cardiac Ischemia

  June 25, 2007

   · 

  1 min read
• BioMidwest

  American Diabetes Association Conference Presentations Highlight Isis Pharmaceuticals, Inc.'s Metabolic Disease Program Research Activities

  June 25, 2007

   · 

  15 min read